Overview
Rei Ishihara practices practicing medicine in Japan.
Ishihara is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Multiple Myeloma, Smith-Magenis Syndrome, Chronic T-Cell Leukemia (CTCL), and Prolymphocytic Leukemia.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rei Ishihara
Is Rei Ishihara a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Rei Ishihara is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rei Ishihara participate in research or clinical trials?
Yes. Rei Ishihara has published 14 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Rei Ishihara's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Multiple MyelomaIshihara isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Chronic T-Cell Leukemia (CTCL)Ishihara isExperienced. Learn about Chronic T-Cell Leukemia (CTCL).
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Prolymphocytic LeukemiaIshihara isExperienced. Learn about Prolymphocytic Leukemia.
- Smith-Magenis SyndromeIshihara isExperienced. Learn about Smith-Magenis Syndrome.